| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.3 |